trial · primary record
AK0406 150 mg
Healthy Participants
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2027-04 |
| Primary endpoint | Adverse events |
| Registry ID | NCT07432698 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:03.271Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07432698
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.